The Circulating Inactive Form of Matrix Gla Protein Is a Surrogate Marker for Vascular Calcification in Chronic Kidney Disease

Leon J. Schurgers1, Daniela Veit Barreto, Fellype Carvalho Barreto, Sophie Liabeuf, C. Renard, Elke J. Magdeleyns, Cees Vermeer, Gabriel Choukroun, Ziad A. Massy
1INSERM ERI-12, Divisions of Clinical Pharmacology and Nephrology, Amiens University Hospital, Avenue René Laennec, F-80054 Amiens, France.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Parfrey, 1999, The clinical epidemiology of cardiac disease in chronic renal failure, J Am Soc Nephrol, 10, 1606, 10.1681/ASN.V1071606

London, 2003, Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality, Nephrol Dial Transplant, 18, 1731, 10.1093/ndt/gfg414

Lehto, 1996, Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus, Arterioscler Thromb Vasc Biol, 16, 978, 10.1161/01.ATV.16.8.978

Schwarz, 2000, Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure, Nephrol Dial Transplant, 15, 218, 10.1093/ndt/15.2.218

Ibels, 1979, Arterial calcification and pathology in uremic patients undergoing dialysis, Am J Med, 66, 790, 10.1016/0002-9343(79)91118-5

Braun, 1996, Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients, Am J Kidney Dis, 27, 394, 10.1016/S0272-6386(96)90363-7

Goodman, 2000, Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, 342, 1478, 10.1056/NEJM200005183422003

Moe, 2004, Natural history of vascular calcification in dialysis and transplant patients, Nephrol Dial Transplant, 19, 2387, 10.1093/ndt/gfh303

Yuen, 2006, The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients, Nephrol Dial Transplant, 21, 1407, 10.1093/ndt/gfl021

Barreto, 2008, Phosphate binder impact on bone remodeling and coronary calcification–results from the BRiC study, Nephron Clin Pract, 110, 273, 10.1159/000170783

Price, 1983, Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone, Biochem Biophys Res Commun, 117, 765, 10.1016/0006-291X(83)91663-7

Munroe, 1999, Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome, Nat Genet, 21, 142, 10.1038/5102

Teebi, 1998, Keutel syndrome: Further characterization and review, Am J Med Genet, 78, 182, 10.1002/(SICI)1096-8628(19980630)78:2<182::AID-AJMG18>3.0.CO;2-J

Luo, 1997, Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein, Nature, 386, 78, 10.1038/386078a0

Shanahan, 2005, Mechanisms of vascular calcification in renal disease, Clin Nephrol, 63, 146, 10.5414/CNP63146

Zebboudj, 2002, Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2, J Biol Chem, 277, 4388, 10.1074/jbc.M109683200

Murshed, 2004, Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins, J Cell Biol, 165, 625, 10.1083/jcb.200402046

Shearer, 1995, Vitamin K, Lancet, 345, 229, 10.1016/S0140-6736(95)90227-9

Schurgers, 2007, Post-translational modifications regulate matrix Gla protein function: Importance for inhibition of vascular smooth muscle cell calcification, J Thromb Haemost, 5, 2503, 10.1111/j.1538-7836.2007.02758.x

Hermans, 2007, Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index, Blood Purif, 25, 395, 10.1159/000108629

Cranenburg, 2008, The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification, J Vasc Res, 45, 427, 10.1159/000124863

Cranenburg, 2009, Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients, Thromb Haemost, 101, 359, 10.1160/TH08-04-0241

Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580

Stevens, 2008, Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD, Am J Kidney Dis, 51, 395, 10.1053/j.ajkd.2007.11.018

Kauppila, 1997, New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study, Atherosclerosis, 132, 245, 10.1016/S0021-9150(97)00106-8

Barreto, 2009, Vitamin D affects survival independently of vascular calcification in chronic kidney disease, Clin J Am Soc Nephrol, 4, 1128, 10.2215/CJN.00260109

Fitzmaurice, 2006, Confounding: Propensity score adjustment, Nutrition, 22, 1214, 10.1016/j.nut.2006.08.015

Shroff, 2008, The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis, Nephrol Dial Transplant, 23, 3263, 10.1093/ndt/gfn226

Schurgers, 2008, Matrix Gla-protein: The calcification inhibitor in need of vitamin K, Thromb Haemost, 100, 593, 10.1160/TH08-02-0087

Parker, 2009, Association of kidney function and uncarboxylated matrix Gla protein: Data from the Heart and Soul Study, Nephrol Dial Transplant, 24, 2095, 10.1093/ndt/gfp024

Schurgers, 2005, Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: Undercarboxylated matrix Gla protein as marker for vascular calcification, Arterioscler Thromb Vasc Biol, 25, 1629, 10.1161/01.ATV.0000173313.46222.43

Kohlmeier, 1995, Variation of phylloquinone (vitamin K1) concentrations in hemodialysis patients, Thromb Haemost, 74, 1252, 10.1055/s-0038-1649921

Pilkey, 2007, Subclinical vitamin K deficiency in hemodialysis patients, Am J Kidney Dis, 49, 432, 10.1053/j.ajkd.2006.11.041

Schurgers, 2004, Oral anticoagulant treatment: Friend or foe in cardiovascular disease?, Blood, 104, 3231, 10.1182/blood-2004-04-1277

Koos, 2005, Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography, Am J Cardiol, 96, 747, 10.1016/j.amjcard.2005.05.014

Schurgers, 2007, Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats, Blood, 109, 2823, 10.1182/blood-2006-07-035345

Geleijnse, 2004, Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study, J Nutr, 134, 3100, 10.1093/jn/134.11.3100

Beulens, 2009, High dietary menaquinone intake is associated with reduced coronary calcification, Atherosclerosis, 203, 489, 10.1016/j.atherosclerosis.2008.07.010